Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-28

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for zolpidem tartrate from Sandoz Inc, enabling an updated/expanded approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)